Postponed Annual General Meeting and Withdrawn Proposal on Dividend Payout due to COVID-19

Stille AB (publ) informs that the board has taken the decision to postpone the annual general meeting to May 27th 2020 and withdraw its previous proposal on dividends due to the ongoing COVID-19 outbreak.

As an effect of the intensified spread of the COVID-19 virus and the subsequent uncertainty in the market, the board has decided to postpone the annual general meeting and withdraw its earlier proposal on dividends of 1.70 SEK per share.

We are monitoring the situation closely in all active markets and evaluating what consequences the pandemic may have on Stille. By postponing the annual general meeting, we gain more time to assess how the situation unfolds and the potential impact it may have, says Stille’s Chairman Göran Brorsson.

In line with the uncertainty around the pandemic’s long-term effects on the company, Stille’s board of directors has also until further notice decided to withdraw its previous proposal on dividends of 1.70 SEK per share.

The company’s financial situation remains strong and there is nothing that excludes the possibility of a new dividend proposal later this year when a general overview of the situation can be obtained. However, under current circumstances, with a strong uncertainty in the market relating to the durability of the measures to slow the spread of the virus and their effect on the business, it is our opinion that it is only responsible to withdraw the proposal on dividends, Stille’s Chairman explains.

Stability and profitability are fundamental to the business, and our financial goals are and will continue to be to provide our shareholders with a stable and long-term return on investment. This decision has been made on the basis of those goals, concludes Göran Borsson.

The Annual General Meeting 2020 will instead be held on May 27th and the notice will be published in accordance with the Articles of Association.

Torshälla, April 1st 2020.

For more information, please contact:

Hanna Ernestam Wilkman
CEO
Telephone: +46 (0)72 402 10 88 
E-mail: hanna.e.wilkman@stille.se

STILLE AB (publ) develops, manufactures and markets medical devices for surgeons across the world. Stille was founded in 1841 and is one of the world’s oldest medical device companies. Stille’s main business areas are surgical instruments and c-arm tables. Stille’s surgical instruments are mostly used during different kinds of open surgery. During minimal invasive procedures, the c-arm tables imagiQ2 and Medstone are key products. The company has a strong brand and products of a renowned high-quality.

The share is listed on First North Growth Market under the acronym “STIL” with Eminova AB as Certified Adviser. Eminova Fondkommission AB, + 46 8 684 211 10, adviser@eminova.se. This information is such information that Stille AB is obliged to disclose according to the EU’s market abuse regulation. The information was, through the agency of the contact person above, rendered for publication on April 1st 2020, kl. 08.00.

For more information about Stille visit www.stille.se